Trikafta
- Product NDC
- 51167-445
- 11-digit product format
- 511670445
- Labeler code
- 51167
- Product ID
- 51167-445_d16848f4-2958-44c0-b688-8a9b25d9032f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Elexacaftor, Tezacaftor, and Ivacaftor
- Dosage form
- KIT
- Labeler
- Vertex Pharmaceuticals Incorporated
- Application
- NDA217660
- Marketing category
- NDA
- Marketing start
- 2023-04-26
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N217660-001 | TRIKAFTA (COPACKAGED) | ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR | 80MG, 60MG, 40MG;59.5MG | GRANULE / ORAL | RLD | 2023-04-26 | |
| N217660-002 | TRIKAFTA (COPACKAGED) | ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR | 100MG, 75MG, 50MG;75MG | GRANULE / ORAL | RLD, RS | 2023-04-26 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N217660-001 | 8354427 | 2026-07-06 | U-3593 | 2023-05-24 | |
| N217660-001 | 8410274 | 2026-12-28 | Drug product | 2023-05-24 | |
| N217660-001 | 8754224 | 2026-12-28 | Drug substance, Drug product | 2023-05-24 | |
| N217660-001 | 9670163 | 2026-12-28 | U-3591 | Drug product | 2023-05-24 |
| N217660-001 | 9670163 | 2026-12-28 | U-4068 | Drug product | 2023-05-24 |
| N217660-001 | 9670163 | 2026-12-28 | U-4478 | Drug product | 2023-05-24 |
| N217660-001 | 9931334 | 2026-12-28 | U-3591 | Drug product | 2023-05-24 |
| N217660-001 | 9931334 | 2026-12-28 | U-4068 | Drug product | 2023-05-24 |
| N217660-001 | 9931334 | 2026-12-28 | U-4478 | Drug product | 2023-05-24 |
| N217660-001 | 10022352 | 2027-04-09 | U-3596 | Drug product | 2023-05-24 |
| N217660-001 | 10239867 | 2027-04-09 | U-3590 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 10239867 | 2027-04-09 | U-4053 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 10239867 | 2027-04-09 | U-4476 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 11639347 | 2027-04-09 | U-3583 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 11639347 | 2027-04-09 | U-4053 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 11639347 | 2027-04-09 | U-4476 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 9974781 | 2027-04-09 | U-3589 | Drug product | 2023-05-24 |
| N217660-001 | 9974781 | 2027-04-09 | U-4066 | Drug product | 2023-05-24 |
| N217660-001 | 9974781 | 2027-04-09 | U-4476 | Drug product | 2023-05-24 |
| N217660-001 | 7645789 | 2027-05-01 | Drug substance, Drug product | 2023-05-24 | |
| N217660-001 | 8598181 | 2027-05-01 | U-3589 | 2023-05-24 | |
| N217660-001 | 8598181 | 2027-05-01 | U-4066 | 2023-05-24 | |
| N217660-001 | 8598181 | 2027-05-01 | U-4476 | 2023-05-24 | |
| N217660-001 | 8623905 | 2027-05-01 | Drug substance, Drug product | 2023-05-24 | |
| N217660-001 | 7495103 | 2027-05-20 | Drug substance, Drug product | 2023-05-24 | |
| N217660-001 | 7776905 | 2027-06-03 | Drug substance, Drug product | 2023-05-24 | |
| N217660-001 | 8324242 | 2027-08-05 | U-3589 | 2023-05-24 | |
| N217660-001 | 8324242 | 2027-08-05 | U-4066 | 2023-05-24 | |
| N217660-001 | 8324242 | 2027-08-05 | U-4476 | 2023-05-24 | |
| N217660-001 | 8415387 | 2027-11-12 | U-3589 | 2023-05-24 | |
| N217660-001 | 8415387 | 2027-11-12 | U-4066 | 2023-05-24 | |
| N217660-001 | 8415387 | 2027-11-12 | U-4476 | 2023-05-24 | |
| N217660-001 | 10646481 | 2029-08-13 | Drug product | 2023-05-24 | |
| N217660-001 | 11564916 | 2029-08-13 | U-3585 | 2023-05-24 | |
| N217660-001 | 11564916 | 2029-08-13 | U-4055 | 2023-05-24 | |
| N217660-001 | 11564916 | 2029-08-13 | U-4485 | 2023-05-24 | |
| N217660-001 | 12458635 | 2029-08-13 | U-4333 | Drug product | 2025-11-21 |
| N217660-001 | 12458635 | 2029-08-13 | U-4493 | Drug product | 2025-11-21 |
| N217660-001 | 10081621 | 2031-03-25 | U-3600 | Drug product | 2023-05-24 |
| N217660-001 | 10081621 | 2031-03-25 | U-4065 | Drug product | 2023-05-24 |
| N217660-001 | 10081621 | 2031-03-25 | U-4481 | Drug product | 2023-05-24 |
| N217660-001 | 11578062 | 2031-03-25 | U-3584 | Drug product | 2023-05-24 |
| N217660-001 | 11578062 | 2031-03-25 | U-4054 | Drug product | 2023-05-24 |
| N217660-001 | 11578062 | 2031-03-25 | U-4488 | Drug product | 2023-05-24 |
| N217660-001 | RE50453 | 2031-07-10 | Drug substance, Drug product | 2025-07-11 | |
| N217660-001 | 10272046 | 2033-02-27 | U-3599 | Drug product | 2023-05-24 |
| N217660-001 | 10272046 | 2033-02-27 | U-4062 | Drug product | 2023-05-24 |
| N217660-001 | 10272046 | 2033-02-27 | U-4482 | Drug product | 2023-05-24 |
| N217660-001 | 11147770 | 2033-02-27 | U-3598 | Drug product | 2023-05-24 |
| N217660-001 | 11147770 | 2033-02-27 | U-4060 | Drug product | 2023-05-24 |
| N217660-001 | 11147770 | 2033-02-27 | U-4483 | Drug product | 2023-05-24 |
| N217660-001 | 11752106 | 2033-02-27 | U-3696 | Drug product | 2023-10-11 |
| N217660-001 | 11752106 | 2033-02-27 | U-4052 | Drug product | 2023-10-11 |
| N217660-001 | 11752106 | 2033-02-27 | U-4489 | Drug product | 2023-10-11 |
| N217660-001 | 12214083 | 2033-02-27 | U-4141 | Drug product | 2025-03-03 |
| N217660-001 | 12214083 | 2033-02-27 | U-4492 | Drug product | 2025-03-03 |
| N217660-001 | 8883206 | 2033-02-27 | Drug product | 2023-05-24 | |
| N217660-001 | 10758534 | 2035-10-06 | U-3589 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 10758534 | 2035-10-06 | U-4066 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 10758534 | 2035-10-06 | U-4476 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 11426407 | 2035-10-06 | U-3595 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 11426407 | 2035-10-06 | U-4058 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 11426407 | 2035-10-06 | U-4476 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 10793547 | 2037-12-08 | U-3588 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 10793547 | 2037-12-08 | U-4066 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 10793547 | 2037-12-08 | U-4476 | Drug substance, Drug product | 2023-05-24 |
| N217660-001 | 11179367 | 2037-12-08 | U-3597 | Drug product | 2023-05-24 |
| N217660-001 | 11179367 | 2037-12-08 | U-4059 | Drug product | 2023-05-24 |
| N217660-001 | 11179367 | 2037-12-08 | U-4484 | Drug product | 2023-05-24 |
| N217660-001 | 11453655 | 2037-12-08 | Drug substance, Drug product | 2023-05-24 | |
| N217660-001 | 11517564 | 2037-12-08 | U-3586 | Drug product | 2023-05-24 |
| N217660-001 | 11517564 | 2037-12-08 | U-4057 | Drug product | 2023-05-24 |
| N217660-001 | 11517564 | 2037-12-08 | U-4476 | Drug product | 2023-05-24 |
| N217660-002 | 8354427 | 2026-07-06 | U-3593 | 2023-05-24 | |
| N217660-002 | 8410274 | 2026-12-28 | Drug product | 2023-05-24 | |
| N217660-002 | 8754224 | 2026-12-28 | Drug substance, Drug product | 2023-05-24 | |
| N217660-002 | 9670163 | 2026-12-28 | U-3591 | Drug product | 2023-05-24 |
| N217660-002 | 9670163 | 2026-12-28 | U-4068 | Drug product | 2023-05-24 |
| N217660-002 | 9670163 | 2026-12-28 | U-4478 | Drug product | 2023-05-24 |
| N217660-002 | 9931334 | 2026-12-28 | U-3591 | Drug product | 2023-05-24 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N217660-001 | NP | 2026-04-26 |
| N217660-001 | M-313 | 2027-12-20 |
| N217660-001 | ODE-433 | 2030-04-26 |
| N217660-001 | ODE-512 | 2031-12-20 |
| N217660-001 | ODE-543 | 2033-03-27 |
| N217660-002 | NP | 2026-04-26 |
| N217660-002 | ODE-433 | 2030-04-26 |
| N217660-002 | ODE-512 | 2031-12-20 |
| N217660-002 | ODE-543 | 2033-03-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULE / ORAL | RLD | 2023-04-26 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULE / ORAL | RLD, RS | 2023-04-26 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULE / ORAL | RLD | 2023-04-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULE / ORAL | RLD, RS | 2023-04-26 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N217660-001 | TRIKAFTA (COPACKAGED) | 80MG, 60MG, 40MG;59.5MG | GRANULES / ORAL | RLD | 2023-04-26 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N217660-002 | TRIKAFTA (COPACKAGED) | 100MG, 75MG, 50MG;75MG | GRANULES / ORAL | RLD, RS | 2023-04-26 | a72a2bbeb626… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 8354427 | 2026-07-06 | U-3593 | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 8410274 | 2026-12-28 | Drug product | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 8754224 | 2026-12-28 | Drug substance, Drug product | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 9670163 | 2026-12-28 | U-4068 | Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 9670163 | 2026-12-28 | U-3591 | Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 9670163 | 2026-12-28 | U-4478 | Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 9931334 | 2026-12-28 | U-4068 | Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 9931334 | 2026-12-28 | U-3591 | Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 9931334 | 2026-12-28 | U-4478 | Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 10022352 | 2027-04-09 | U-3596 | Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 10239867 | 2027-04-09 | U-3590 | Drug substance, Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 10239867 | 2027-04-09 | U-4053 | Drug substance, Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 10239867 | 2027-04-09 | U-4476 | Drug substance, Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 11639347 | 2027-04-09 | U-3583 | Drug substance, Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 11639347 | 2027-04-09 | U-4053 | Drug substance, Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 11639347 | 2027-04-09 | U-4476 | Drug substance, Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 9974781 | 2027-04-09 | U-4066 | Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 9974781 | 2027-04-09 | U-3589 | Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 9974781 | 2027-04-09 | U-4476 | Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 7645789 | 2027-05-01 | Drug substance, Drug product | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 8598181 | 2027-05-01 | U-4066 | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 8598181 | 2027-05-01 | U-3589 | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 8598181 | 2027-05-01 | U-4476 | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 8623905 | 2027-05-01 | Drug substance, Drug product | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 7495103 | 2027-05-20 | Drug substance, Drug product | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 7776905 | 2027-06-03 | Drug substance, Drug product | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 8324242 | 2027-08-05 | U-4066 | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 8324242 | 2027-08-05 | U-3589 | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 8324242 | 2027-08-05 | U-4476 | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 8415387 | 2027-11-12 | U-3589 | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 8415387 | 2027-11-12 | U-4066 | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 8415387 | 2027-11-12 | U-4476 | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 10646481 | 2029-08-13 | Drug product | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 11564916 | 2029-08-13 | U-3585 | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 11564916 | 2029-08-13 | U-4055 | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 11564916 | 2029-08-13 | U-4485 | 2023-05-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 12458635 | 2029-08-13 | U-4333 | Drug product | 2025-11-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 12458635 | 2029-08-13 | U-4493 | Drug product | 2025-11-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 10081621 | 2031-03-25 | U-4065 | Drug product | 2023-05-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | 10081621 | 2031-03-25 | U-3600 | Drug product | 2023-05-24 | 84e616aacf4f… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | NP | 2026-04-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | M-313 | 2027-12-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | ODE-433 | 2030-04-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | ODE-512 | 2031-12-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-001 | ODE-543 | 2033-03-27 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-002 | NP | 2026-04-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-002 | ODE-433 | 2030-04-26 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-002 | ODE-512 | 2031-12-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217660-002 | ODE-543 | 2033-03-27 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N217660-001 | NP | 2026-04-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217660-001 | M-313 | 2027-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217660-001 | ODE-433 | 2030-04-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217660-001 | ODE-512 | 2031-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217660-001 | ODE-543 | 2033-03-27 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217660-002 | NP | 2026-04-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217660-002 | ODE-433 | 2030-04-26 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217660-002 | ODE-512 | 2031-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217660-002 | ODE-543 | 2033-03-27 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N217660-001 | NP | 2026-04-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N217660-001 | M-313 | 2027-12-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N217660-001 | ODE-433 | 2030-04-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N217660-001 | ODE-512 | 2031-12-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N217660-002 | NP | 2026-04-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N217660-002 | ODE-433 | 2030-04-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N217660-002 | ODE-512 | 2031-12-20 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217660-001 | NP | 2026-04-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217660-001 | M-313 | 2027-12-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217660-001 | ODE-433 | 2030-04-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217660-001 | ODE-512 | 2031-12-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217660-002 | NP | 2026-04-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217660-002 | ODE-433 | 2030-04-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217660-002 | ODE-512 | 2031-12-20 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N217660-001 | NP | 2026-04-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N217660-001 | M-313 | 2027-12-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N217660-001 | ODE-433 | 2030-04-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N217660-001 | ODE-512 | 2031-12-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N217660-002 | NP | 2026-04-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N217660-002 | ODE-433 | 2030-04-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N217660-002 | ODE-512 | 2031-12-20 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217660-001 | NP | 2026-04-26 | fd3edfee7708… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Trikafta
- Listing expiration
- 2027-12-31
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1243046 | Internal RxNorm lookup |
| 1606868 | Internal RxNorm lookup |
| 2174388 | Internal RxNorm lookup |
| 2257011 | Internal RxNorm lookup |
| 2257012 | Internal RxNorm lookup |
| 2257013 | Internal RxNorm lookup |
| 2557214 | Internal RxNorm lookup |
| 2557215 | Internal RxNorm lookup |
| 2557216 | Internal RxNorm lookup |
| 2635013 | Internal RxNorm lookup |
| 2635020 | Internal RxNorm lookup |
| 2635021 | Internal RxNorm lookup |
| 2635022 | Internal RxNorm lookup |
| 2635024 | Internal RxNorm lookup |
| 2635025 | Internal RxNorm lookup |
| 2635026 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f354423a-85c2-41c3-a9db-0f3aee135d8d | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 29f82424-66ff-4356-862a-3564547225ea | Product name | 1 | 20250819 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 3345c65e-7c51-4ee3-a410-af7ec8592f92 | Product name | 2 | 20231010 |
| 31b21435-431d-4752-a7c5-89c6a41c6338 | Product name | 4 | 20230626 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| eaf14f5a-a483-45c2-b6bb-bda37f923e37 | Product name | 1 | 20180508 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 1c108d2a-865b-9f48-5b3a-b52233297e1d | Product name | 2 | 20150417 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
| d723478e-ad4a-ec23-6bd7-cfe33e1e3840 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51167-445-01 | Trikafta | 1 in 1 PACKAGE | KIT | 1 | 22 | |
| 51167-445-01 | Trikafta | 4 in 1 CARTON | KIT | 4 | 22 | |
| 51167-545-07 | Trikafta | 1 in 1 PACKET | GRANULE | 7 | 80 mg | 22 |
| 51167-645-07 | Trikafta | 1 in 1 PACKET | GRANULE | 7 | 59.5 mg | 22 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51167-445-01 | EA - Each | 51167-445 | a481db85-c2bd-4a16-bd23-9dcae0f3165b | 1 | 2023-05-05 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Trikafta | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | Vertex Pharmaceuticals Incorporated | f354423a-85c2-41c3-a9db-0f3aee135d8d | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | 217660 NDA217660 51167-445 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2635026 | {28 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Granules) / 28 (ivacaftor 75 MG Oral Granules) } Pack [Trikafta (100 MG / 50 MG / 75 MG; 75 MG) Granules] | BPCK | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635022 | {28 (elexacaftor 80 MG / ivacaftor 60 MG / tezacaftor 40 MG Oral Granules) / 28 (ivacaftor 59.5 MG Oral Granules) } Pack [Trikafta (80 MG / 40 MG / 60 MG; 59.5 MG) Granules] | BPCK | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2257013 | {56 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet) / 28 (ivacaftor 150 MG Oral Tablet) } Pack [Trikafta (100 MG / 50 MG / 75 MG; 150 MG)] | BPCK | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2557216 | {56 (elexacaftor 50 MG / ivacaftor 37.5 MG / tezacaftor 25 MG Oral Tablet) / 28 (ivacaftor 75 MG Oral Tablet) } Pack [Trikafta (50 MG / 37.5 MG / 25 MG; 75 MG)] | BPCK | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635025 | {28 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Granules) / 28 (ivacaftor 75 MG Oral Granules) } Pack | GPCK | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635021 | {28 (elexacaftor 80 MG / ivacaftor 60 MG / tezacaftor 40 MG Oral Granules) / 28 (ivacaftor 59.5 MG Oral Granules) } Pack | GPCK | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2257012 | {56 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet) / 28 (ivacaftor 150 MG Oral Tablet) } Pack | GPCK | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2557215 | {56 (elexacaftor 50 MG / ivacaftor 37.5 MG / tezacaftor 25 MG Oral Tablet) / 28 (ivacaftor 75 MG Oral Tablet) } Pack | GPCK | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635024 | elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Granules | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635025 | elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Granules (28) / ivacaftor 75 MG Oral Granules (28) Pack | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2257011 | elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2257012 | elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet (56) and ivacaftor 150 MG Oral Tablet (28) Pack | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2557214 | elexacaftor 50 MG / ivacaftor 37.5 MG / tezacaftor 25 MG Oral Tablet | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2557215 | elexacaftor 50 MG / ivacaftor 37.5 MG / tezacaftor 25 MG Oral Tablet (56) and ivacaftor 75 MG Oral Tablet (28) Pack | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635013 | elexacaftor 80 MG / ivacaftor 60 MG / tezacaftor 40 MG Oral Granules | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635021 | elexacaftor 80 MG / ivacaftor 60 MG / tezacaftor 40 MG Oral Granules (28) / ivacaftor 59.5 MG Oral Granules (28) Pack | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 1243046 | ivacaftor 150 MG Oral Tablet | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635020 | ivacaftor 59.5 MG Oral Granules | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 1606868 | ivacaftor 75 MG Oral Granules | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2174388 | ivacaftor 75 MG Oral Tablet | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2257013 | trikafta 100 MG / 50 MG / 75 MG and 150 MG Tablet Pack | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635026 | trikafta 100 MG / 50 MG / 75 MG and 75 MG Oral Granules Pack | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2557216 | trikafta 50 MG / 37.5 MG / 25 MG and 75 MG Pack | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635022 | trikafta 80 MG / 40 MG / 60 MG and 59.5 MG Oral Granules Pack | PSN | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635024 | elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Granules | SCD | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2257011 | elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet | SCD | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2557214 | elexacaftor 50 MG / ivacaftor 37.5 MG / tezacaftor 25 MG Oral Tablet | SCD | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635013 | elexacaftor 80 MG / ivacaftor 60 MG / tezacaftor 40 MG Oral Granules | SCD | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 1243046 | ivacaftor 150 MG Oral Tablet | SCD | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635020 | ivacaftor 59.5 MG Oral Granules | SCD | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 1606868 | ivacaftor 75 MG Oral Granules | SCD | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2174388 | ivacaftor 75 MG Oral Tablet | SCD | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635025 | elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Granules (28) / ivacaftor 75 MG Oral Granules (28) Pack | SY | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2257012 | elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet (56) and ivacaftor 150 MG Oral Tablet (28) Pack | SY | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2557215 | elexacaftor 50 MG / ivacaftor 37.5 MG / tezacaftor 25 MG Oral Tablet (56) and ivacaftor 75 MG Oral Tablet (28) Pack | SY | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635021 | elexacaftor 80 MG / ivacaftor 60 MG / tezacaftor 40 MG Oral Granules (28) / ivacaftor 59.5 MG Oral Granules (28) Pack | SY | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2257013 | trikafta 100 MG / 50 MG / 75 MG and 150 MG Tablet Pack | SY | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635026 | Trikafta 100 MG / 50 MG / 75 MG and 75 MG Oral Granules Pack | SY | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2557216 | trikafta 50 MG / 37.5 MG / 25 MG and 75 MG Pack | SY | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
| 2635022 | Trikafta 80 MG / 40 MG / 60 MG and 59.5 MG Oral Granules Pack | SY | f354423a-85c2-41c3-a9db-0f3aee135d8d | 22 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 51167-445-01 | 51167044501 | 4 PACKAGE in 1 CARTON (51167-445-01) / 1 KIT in 1 PACKAGE * 1 GRANULE in 1 PACKET (51167-545-07) * 1 GRANULE in 1 PACKET (51167-645-07) | 4 package | 2023-04-26 | No | No | Current |
| 51167-545-07 | 51167054507 | 1 in 1 PACKET | Historical | ||||
| 51167-645-07 | 51167064507 | 1 in 1 PACKET | Historical |